UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 345

Sortiert nach

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

Neurobiology of disease, 2021-02, Vol.149, p.105229, Article 105229

2021

Volltextzugriff (PDF)

Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology

The European journal of neuroscience, 2010-08, Vol.32 (3), p.409-422

2010

Volltextzugriff (PDF)

Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

Neurobiology of disease, 2013-08, Vol.56, p.47-58

2013

Volltextzugriff (PDF)

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity

Acta neuropathologica communications, 2018-07, Vol.6 (1), p.54-17, Article 54

2018

Volltextzugriff (PDF)

Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production

Neurobiology of disease, 2017-10, Vol.106, p.49-62

2017

Volltextzugriff (PDF)

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response

Acta neuropathologica communications, 2021-06, Vol.9 (1), p.1-105, Article 105

2021

Volltextzugriff (PDF)

Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain

Frontiers in neuroscience, 2019-11, Vol.13, p.1187-1187

2019

Volltextzugriff (PDF)

Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo

The Journal of neuroscience, 2012-03, Vol.32 (10), p.3301-3305

2012

Volltextzugriff (PDF)

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson's disease

NPJ Parkinson's Disease, 2023-12, Vol.9 (1), p.164-164, Article 164

2023

Volltextzugriff (PDF)

FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy

PloS one, 2013-01, Vol.8 (1), p.e55243

2013

Volltextzugriff (PDF)

Identification of Novel α‐Synuclein Assemblies in Lewy Body Disease

Movement disorders, 2023-01, Vol.38 (1), p.21-22

2023

Volltextzugriff (PDF)

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

Brain (London, England : 1878), 2014-05, Vol.137 (5), p.1496-1513

2014

Volltextzugriff (PDF)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9

Neuroscience insights, 2019-11, Vol.14, p.1179069519889022-1179069519889022

2019

Volltextzugriff (PDF)

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

Brain (London, England : 1878), 2010-03, Vol.133 (3), p.713-726

2010

Volltextzugriff (PDF)

Corrigendum to “Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease” [Neurobiol. Dis. 56 (2013) 48–58]

Neurobiology of disease, 2013-10, Vol.58, p.191-191

2013

Volltextzugriff (PDF)

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats

Brain (London, England : 1878), 2013-02, Vol.136 (Pt 2), p.412-432

2013

Volltextzugriff (PDF)

Down-Regulation of Parkin Protein in Transient Focal Cerebral Ischemia: A Link between Stroke and Degenerative Disease?

Proceedings of the National Academy of Sciences - PNAS, 2002-11, Vol.99 (23), p.15042-15047

2002

Volltextzugriff (PDF)

Incipient intranuclear inclusion body disease in a 78‐year‐old woman

Neuropathology, 2011-04, Vol.31 (2), p.188-193

2011

Volltextzugriff (PDF)

Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Brain (London, England : 1878), 2009-04, Vol.132 (4), p.1093-1101

2009

Volltextzugriff (PDF)

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Brain (London, England : 1878), 2009-04, Vol.132 (4), p.1093-1101

2009

Volltextzugriff (PDF)

Characterizing the Dynamics of α‑Synuclein Oligomers Using Hydrogen/Deuterium Exchange Monitored by Mass Spectrometry

Biochemistry (Easton), 2013-12, Vol.52 (51), p.9097-9103

2013

Volltextzugriff (PDF)

A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Journal of Alzheimer's disease, 2018-01, Vol.61 (4), p.1541

2018

Volltextzugriff (PDF)

Proteasomal Inhibition by α-Synuclein Filaments and Oligomers

The Journal of biological chemistry, 2004-03, Vol.279 (13), p.12924-12934

2004

Volltextzugriff (PDF)

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting

Neurology, 2018-01, Vol.90 (2), p.74

2018

Volltextzugriff (PDF)

p25α Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy

The American journal of pathology, 2007-10, Vol.171 (4), p.1291-1303

2007

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(312)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(250)
Life Sciences & Biomedicine
(180)
Humans
(131)
Female
(75)
Biological And Medical Sciences
(71)
Male
(68)
Physical Sciences
(63)
Neurosciences & Neurology
(50)
Middle Aged
(49)
Physics
(49)
Neurosciences
(48)
Medical Sciences
(47)
Biochemistry & Molecular Biology
(45)
Aged
(44)
Exact Sciences And Technology
(44)
Chemistry
(42)
Adult
(40)
Chemistry, Physical
(34)
Atomic And Molecular Physics
(31)
Physics, Atomic, Molecular & Chemical
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology

Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity

Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production

α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response

Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain

Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo

Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson's disease

FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy

Identification of Novel α‐Synuclein Assemblies in Lewy Body Disease

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

Corrigendum to “Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease” [Neurobiol. Dis. 56 (2013) 48–58]

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats

Down-Regulation of Parkin Protein in Transient Focal Cerebral Ischemia: A Link between Stroke and Degenerative Disease?

Incipient intranuclear inclusion body disease in a 78‐year‐old woman

Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Characterizing the Dynamics of α‑Synuclein Oligomers Using Hydrogen/Deuterium Exchange Monitored by Mass Spectrometry

A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Proteasomal Inhibition by α-Synuclein Filaments and Oligomers

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting

p25α Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy

Suchergebnisse filtern